Global Peyronie’s Disease Treatment Market Size To Worth USD 2.68 Billion by 2033 | CAGR of 7.93%
Category: HealthcareGlobal Peyronie’s Disease Treatment Market Size To Worth USD 2.68 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Peyronie’s Disease Treatment Market Size is to Grow from USD 1.25 Billion in 2023 to USD 2.68 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.93% during the projected period.
Get more details on this report -
Browse key industry insights spread across 269 pages with 119 Market data tables and figures & charts from the report on the "Global Peyronie’s Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Route Of Administration (Oral, Topical, Injectable), By Technology (Collagenase Injections, Shockwave Therapy, Surgery, Oral Medications, Topical Treatments), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/peyronie-s-disease-treatment-market
Peyronie's disease is a condition characterized by the development of fibrous scar tissue, or plaque, inside the penis, leading to abnormal curvature during erection. This can cause pain, discomfort, and difficulties with sexual intercourse, significantly impacting a patient's quality of life. The exact cause of Peyronie's disease is often unclear but may involve trauma or genetic factors. Treatment options vary depending on the severity of the condition. Initial management may include oral medications and topical treatments to reduce pain and inflammation. For more severe cases, injectable treatments such as collagenase clostridium histolyticum (Xiaflex) can help break down the plaque, and shockwave therapy may improve blood flow and reduce curvature. Surgical intervention is considered for patients with significant curvature or dysfunction that does not respond to non-invasive treatments. Each treatment aims to alleviate symptoms, restore function, and improve overall well-being. However, Peyronie's disease treatment, especially with collagenase, can lead to side effects like pain, swelling, and, in rare cases, penile rupture or bruising.
The injectable segment is anticipated to hold the greatest share of the global Peyronie’s disease treatment market during the projected timeframe.
Based on the route of administration, the global Peyronie’s disease treatment market is divided into oral, topical, and injectable. Among these, the oral, topical, and injectable segment is anticipated to hold the greatest share of the global Peyronie’s disease treatment market during the projected timeframe. The injectable segment of Peyronie's disease treatment market is predicted to develop significantly due to increased usage of collagenase injections such as Xiaflex.
The collagenase injections segment is anticipated to grow at the fastest pace in the global Peyronie’s disease treatment market during the projected timeframe.
Based on the treatment, the global Peyronie’s disease treatment market is divided into collagenase injections, shockwave therapy, surgery, oral medications, and topical treatments. Among these, the collagenase injections segment is anticipated to grow at the fastest pace in the global Peyronie’s disease treatment market during the projected timeframe. Collagenase injections, a non-surgical treatment for plaque-causing penile curvature, are gaining popularity due to their efficacy and safety, with growth expected in this segment.
The specialty clinics segment is anticipated to grow at the fastest pace in the global Peyronie’s disease treatment market during the projected timeframe.
Based on the end-user, the global Peyronie’s disease treatment market is divided into hospitals, specialty clinics, and ambulatory surgical centers. Among these, the specialty clinics segment is anticipated to grow at the fastest pace in the global Peyronie’s disease treatment market during the projected timeframe. Specialty Clinics are expected to experience significant growth in Peyronie's disease treatment due to their personalized care, advanced treatments, and shorter wait times compared to hospitals.
North America is expected to hold the largest share of the global Peyronie’s disease treatment market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global Peyronie’s disease treatment market over the forecast period. The US leads Peyronie's disease treatment market due to its high prevalence, healthcare infrastructure, advanced treatments, strong healthcare expenditure, favorable reimbursement policies, and key pharmaceutical companies.
Asia Pacific is predicted to grow at the fastest pace in the global Peyronie’s disease treatment market during the projected timeframe. The Peyronie's disease market in Asia-Pacific countries is expanding due to increased awareness, improved healthcare infrastructure, rising healthcare expenditures, an aging male population, advanced medical treatments, and a sexual health focus.
Major vendors in the Global Peyronie’s Disease Treatment Market include Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Bayer AG, AstraZeneca, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Mylan N.V., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, and Others.
Recent Developments
- In July 2023, Endo International enrolled the first patient in CURVE-PD, a non-interventional registry for up to 1,000 patients with Peyronie's disease.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Peyronie’s Disease Treatment Market based on the below-mentioned segments:
Global Peyronie’s Disease Treatment Market, By Route of Administration
- Oral
- Topical
- Injectable
Global Peyronie’s Disease Treatment Market, By Treatment
- Collagenase Injections
- Shockwave Therapy
- Surgery
- Oral Medications
- Topical Treatments
Global Peyronie’s Disease Treatment Market, By End-User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Peyronie’s Disease Treatment Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?